Education
About Us
Working with TipRanks
Follow Us
Orthopediatrics Corp (KIDS)
:KIDS
KIDS Stock Chart & Stats
$17.57
-$0.10(-0.41%)
At close: 4:00 PM EST
$17.57
-$0.10(-0.41%)
Day’s Range― - ―
52-Week Range$15.28 - $27.60
Previous CloseN/A
Volume20.12K
Average Volume (3M)190.51K
Market Cap
$434.34M
Enterprise Value$477.64M
Total Cash (Recent Filing)$57.73M
Total Debt (Recent Filing)$99.34M
Price to Earnings (P/E)―
Beta0.68
Next Earnings
Mar 11, 2026EPS Estimate
-0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding25,077,330
10 Day Avg. Volume164,907
30 Day Avg. Volume190,509
Financial Highlights & Ratios
PEG Ratio-0.18
Price to Book (P/B)1.51
Price to Sales (P/S)2.61
P/FCF Ratio-12.95
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue2.10
Enterprise Value/Gross Profit2.93
Enterprise Value/Ebitda-33.13
Forecast
1Y Price Target
$24.00Price Target Upside36.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)-1.34
Revenue Forecast (FY)$234.00M
Bulls Say, Bears Say
Bulls Say
Market PositioningKIDS has established a strong position within the pediatric orthopedic device market, spanning a continuum of surgical interventions to conservative care options across its Trauma & Deformity and Scoliosis segments.
Product Launch CycleWith the company at the beginning of a new product launch cycle, KIDS is poised to continue driving double-digit growth, significantly above many orthopedic peers, in the years to come.
Strategic AcquisitionsIntegral to KIDS' strategy are serial M&A/partnership opportunities, notably its acquisition of Boston Orthotics and Prosthetics, which gave KIDS a strong foothold in orthopedic bracing, allowing it to address a broader spectrum of pediatric orthopedic needs.
Bears Say
Lowered Price TargetAnalyst lowers the price target to $26 from $42 given the lower revenue growth forecasts.
Revenue Growth SlowdownRevenue growth slowed to 12% in 3Q25 from 16% in 2Q25, driven by lower 7D sales.
Revenue Guidance ReductionManagement lowered 2025 revenue guidance to $233.5-234.5M from $237-242M, which is below consensus expectations.
OrthoPediatrics News
KIDS FAQ
What was Orthopediatrics Corp’s price range in the past 12 months?
Orthopediatrics Corp lowest stock price was $15.28 and its highest was $27.60 in the past 12 months.
What is Orthopediatrics Corp’s market cap?
Orthopediatrics Corp’s market cap is $434.34M.
When is Orthopediatrics Corp’s upcoming earnings report date?
Orthopediatrics Corp’s upcoming earnings report date is Mar 11, 2026 which is in 81 days.
How were Orthopediatrics Corp’s earnings last quarter?
Orthopediatrics Corp released its earnings results on Oct 28, 2025. The company reported -$0.24 earnings per share for the quarter, beating the consensus estimate of -$0.258 by $0.018.
Is Orthopediatrics Corp overvalued?
According to Wall Street analysts Orthopediatrics Corp’s price is currently Undervalued.
Does Orthopediatrics Corp pay dividends?
Orthopediatrics Corp does not currently pay dividends.
What is Orthopediatrics Corp’s EPS estimate?
Orthopediatrics Corp’s EPS estimate is -0.32.
How many shares outstanding does Orthopediatrics Corp have?
Orthopediatrics Corp has 25,077,330 shares outstanding.
What happened to Orthopediatrics Corp’s price movement after its last earnings report?
Orthopediatrics Corp reported an EPS of -$0.24 in its last earnings report, beating expectations of -$0.258. Following the earnings report the stock price went down -2.661%.
Which hedge fund is a major shareholder of Orthopediatrics Corp?
Currently, no hedge funds are holding shares in KIDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OrthoPediatrics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$24.00 (36.60% Upside)
$24.00 (36.60% Upside)
Blogger Sentiment
Bullish
KIDS Sentiment 70%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 165.8K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.31%
12-Months-Change
Fundamentals
Return on Equity
-12.67%
Trailing 12-Months
Asset Growth
0.86%
Trailing 12-Months
Company Description
Orthopediatrics Corp
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
KIDS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial and operational performance, including record revenue growth and successful strategic expansions in key market segments such as Scoliosis and OPSB. However, there were challenges such as a decline in gross margin, slower than expected T&D growth, and restructuring charges. Overall, the positive aspects of the company's performance and future outlook significantly outweigh the negatives.View all KIDS earnings summariesKIDS Stock 12 Month Forecast
Average Price Target
$24.00
▲(36.60% Upside)
Technical Analysis
Ownership Overview
32.72% Insiders
15.52% Mutual Funds
23.39% Other Institutional Investors
20.51% Public Companies and
Individual Investors